Related Experiment Video
Updated: Jul 9, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Evidence and structural mechanism for late lung alveolarization
Johannes C Schittny1, Sonja I Mund, Marco Stampanoni
1Institute of Anatomy, University of Bern, Baltzerstrasse 2, Bern, Switzerland. johannes.schittny@ana.unibe.ch
Lung development continues into young adulthood, with new alveolar septa forming even after microvasculature maturation. This challenges the view that alveolarization stops early, suggesting ongoing lung plasticity.
Area of Science:
- Pulmonary biology
- Developmental biology
- Respiratory medicine
Background:
- Current understanding posits alveolar septa formation ceases post-microvasculature maturation (postnatal days 14-21 in rats).
- This maturation involves reducing alveolar septal capillaries from double- to single-layered networks.
Purpose of the Study:
- To challenge the established view on the cessation of alveolar septa formation.
- To investigate the timeline and mechanisms of alveolar septa development and microvasculature changes in rats.
Main Methods:
- Stereological measurements of new alveolar septa formation.
- Three-dimensional (3-D) visualizations using high-resolution synchrotron radiation X-ray tomographic microscopy.
- Analysis of alveolar capillary networks in developing rat lungs.
Main Results:
- New alveolar septa formation occurs at least until young adulthood (rats, days 4-60).
- Approximately half of newly formed septa originate from mature septa with single-layered capillary networks.
- Local duplication of the capillary network was observed at the base of newly forming septa.
Conclusions:
- Alveologenesis can occur at any time and location within the lung parenchyma, indicating continuous lung development into young adulthood.
- Two distinct phases of developmental alveolarization were identified: phase one (days 4-21) and phase two (day 14 through young adulthood).
- Clinical implications suggest caution when using drugs that affect structural lung development during these phases.
Related Concept Videos
Atelectasis II: Pathophysiology
Alveoli and Alveolar Ducts
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema
Pneumothorax II: Pathophysiology
Gross Anatomy of the Lungs

